36
Participants
Start Date
February 29, 2008
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Botulism Antitoxin Bivalent (Equine) Types A and B
One vial of Botulism Antitoxin Bivalent(Equine) Types A and B (1:10 in saline) or an Equivalent Volume of Placebo on Day 0 in Stage A
Botulism Antitoxin Heptavalent (Equine) Types A-G
One vial of Heptavalent Botulism Antitoxin (1:10 in saline) or an Equivalent Volume of Placebo on Day 0 in Stage B
Dr. Gordon Peterson, Loma Linda
R. Richard Sloop, M. D., Yakima
Lead Sponsor
Department of Health and Human Services
FED
Emergent BioSolutions
INDUSTRY